Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Raingeard

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Clinical Endocrinology|June 8, 2011
Early detection of isolated left ventricular diastolic dysfunction in high-risk differentiated thyroid carcinoma patients on TSH-suppressive therapyVéronique Taillard, Mathieu Sardinoux, Carole Oudot, et al.
Pituitary|July 12, 2024
Outcome of non-functioning ACTH pituitary tumors: silent does not mean indolentNicolas Sahakian, Lise Goetz, Romain Appay, et al.
Annales D'Endocrinologie|July 13, 2021
Pegvisomant treatment in acromegaly in clinical practice: Final results of the French ACROSTUDY (312 patients)Sara Barraud, Philippe Caron, Isabelle Raingeard, et al.
Reproductive Biology and Endocrinology : RB&E|March 23, 2010
Steroidogenic factor-1 (SF-1) gene mutation as a frequent cause of primary amenorrhea in 46,XY female adolescents with low testosterone concentrationPascal Philibert, Elodie Leprieur, Delphine Zenaty, et al.
European Journal of Endocrinology|October 29, 2021
Lack of delayed neurocognitive side effects of Gamma Knife radiosurgery in acromegaly: the Later-Ac studyFrederic Castinetti, Philippe Caron, Isabelle Raingeard, et al.
Endocrine|November 6, 2020
Correction to: Pegvisomant in combination or pegvisomant alone after failure of somatostatin analogs in acromegaly patients: an observational French ACROSTUDY cohort studyEmmanuelle Kuhn, Philippe Caron, Brigitte Delemer, et al.
Endocrine|September 28, 2020
Pegvisomant in combination or pegvisomant alone after failure of somatostatin analogs in acromegaly patients: an observational French ACROSTUDY cohort studyEmmanuelle Kuhn, Philippe Caron, Brigitte Delemer, et al.
Advances in Therapy|July 20, 2020
Evaluation of Nurses' and Patients' Overall Satisfaction with New and Previous Formulations of Octreotide Long-acting Release (Sandostatin LAR<sup>®</sup>): A French Observational StudyBrigitte Delemer, Thierry Nguyen-Tan-Hon, Romain Coriat, et al.
Clinical Chemistry|October 24, 2007
Global sequencing approach for characterizing the molecular background of hereditary iron disordersSéverine Cunat, Muriel Giansily-Blaizot, Michael Bismuth, et al.
European Journal of Endocrinology|June 13, 2013
The clinical spectrum of RET proto-oncogene mutations in codon 790Hélène Bihan, Arnaud Murat, Marinos Fysekidis, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Clinical Endocrinology|June 8, 2011
Early detection of isolated left ventricular diastolic dysfunction in high-risk differentiated thyroid carcinoma patients on TSH-suppressive therapyVéronique Taillard, Mathieu Sardinoux, Carole Oudot, et al.
Pituitary|July 12, 2024
Outcome of non-functioning ACTH pituitary tumors: silent does not mean indolentNicolas Sahakian, Lise Goetz, Romain Appay, et al.
Annales D'Endocrinologie|July 13, 2021
Pegvisomant treatment in acromegaly in clinical practice: Final results of the French ACROSTUDY (312 patients)Sara Barraud, Philippe Caron, Isabelle Raingeard, et al.
Reproductive Biology and Endocrinology : RB&E|March 23, 2010
Steroidogenic factor-1 (SF-1) gene mutation as a frequent cause of primary amenorrhea in 46,XY female adolescents with low testosterone concentrationPascal Philibert, Elodie Leprieur, Delphine Zenaty, et al.
European Journal of Endocrinology|October 29, 2021
Lack of delayed neurocognitive side effects of Gamma Knife radiosurgery in acromegaly: the Later-Ac studyFrederic Castinetti, Philippe Caron, Isabelle Raingeard, et al.
Endocrine|November 6, 2020
Correction to: Pegvisomant in combination or pegvisomant alone after failure of somatostatin analogs in acromegaly patients: an observational French ACROSTUDY cohort studyEmmanuelle Kuhn, Philippe Caron, Brigitte Delemer, et al.
Endocrine|September 28, 2020
Pegvisomant in combination or pegvisomant alone after failure of somatostatin analogs in acromegaly patients: an observational French ACROSTUDY cohort studyEmmanuelle Kuhn, Philippe Caron, Brigitte Delemer, et al.
Advances in Therapy|July 20, 2020
Evaluation of Nurses' and Patients' Overall Satisfaction with New and Previous Formulations of Octreotide Long-acting Release (Sandostatin LAR<sup>®</sup>): A French Observational StudyBrigitte Delemer, Thierry Nguyen-Tan-Hon, Romain Coriat, et al.
Clinical Chemistry|October 24, 2007
Global sequencing approach for characterizing the molecular background of hereditary iron disordersSéverine Cunat, Muriel Giansily-Blaizot, Michael Bismuth, et al.
European Journal of Endocrinology|June 13, 2013
The clinical spectrum of RET proto-oncogene mutations in codon 790Hélène Bihan, Arnaud Murat, Marinos Fysekidis, et al.
Pageof 4